Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment

被引:172
作者
Le Berre, Catherine [1 ,2 ]
Ananthakrishnan, Ashwin N. [3 ]
Danese, Silvio [4 ,5 ]
Singh, Siddharth [6 ]
Peyrin-Biroulet, Laurent [1 ]
机构
[1] Univ Lorraine, Nancy Univ Hosp, Dept Gastroenterol, INSERM,U954, 1 Allee Morvan, F-54511 Vandoeuvre Les Nancy, France
[2] Nantes Univ Hosp, Inst Malad Appareil Digestif, Nantes, France
[3] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA
[4] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[5] Humanitas Clin & Res Ctr, Dept Gastroenterol, Ctr Inflammatory Bowel Dis, Milan, Italy
[6] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA
关键词
IBD; Severity; Disability; Treat to Target; INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; ANTI-TNF THERAPY; FECAL CALPROTECTIN; CLINICAL-COURSE; RISK-FACTORS; EXTRAINTESTINAL MANIFESTATIONS; NATURAL-HISTORY; WORK DISABILITY;
D O I
10.1016/j.cgh.2019.07.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
It is unclear whether ulcerative colitis (UC) is a progressive disease similar to Crohn's disease (CD). Patients with UC often are undertreated because of the possibility of curative colectomy and the perception that the disease burden is lower than that of CD. We discuss findings from studies that aimed to determine whether UC and CD have the same disease burden and should be treated in the same intensive way. We discuss the similarities between CD and UC, including effects on quality of life, long-term complications, strictures, increased risk of cancer, pseudopolyps, functional abnormalities, and anorectal dysfunction. Contrary to the generally accepted idea, surgery cannot cure UC. Postoperative complications, especially pouchitis and fecal incontinence, affect more than one third of patients. CD and UC each pose substantial economic burdens. Monitoring, treatments, and goals of therapy are similar for all inflammatory bowel diseases. Earlier initiation of disease-modifying drugs might reduce the progression of UC and reduce its burden after surgery, although UC might not cause the irreversible damage observed in patients with CD.
引用
收藏
页码:14 / 23
页数:10
相关论文
共 83 条
[1]   SIGNIFICANCE OF WIDENING OF PRESACRAL SPACE AT CONTRAST RADIOGRAPHY IN INFLAMMATORY BOWEL-DISEASE [J].
ALP, MH ;
SAGE, MR ;
GRANT, AK .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1978, 48 (02) :175-177
[2]   Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study [J].
Barreiro-de Acosta, Manuel ;
Vallejo, Nicolau ;
de la Iglesia, Daniel ;
Uribarri, Laura ;
Baston, Iria ;
Ferreiro-Iglesias, Rocio ;
Lorenzo, Aurelio ;
Enrique Dominguez-Munoz, J. .
JOURNAL OF CROHNS & COLITIS, 2016, 10 (01) :13-19
[3]   Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort [J].
Bossuyt, Peter ;
Baert, Filip ;
D'Heygere, Francois ;
Nakad, Antoine ;
Reenaers, Catherine ;
Fontaine, Fernand ;
Franchimont, Denis ;
Dewit, Olivier ;
Van Hootegem, Philippe ;
Vanden Branden, Stijn ;
Lambrecht, Guy ;
Ferrante, Marc ;
Hindryckx, Pieter ;
Macken, Elisabeth ;
Caenepeel, Philip ;
Vijverman, Anne ;
de Suray, Nicolas ;
Dutre, Joris ;
Louis, Edouard ;
Coenegracths, Jean-Louis .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (01) :156-162
[4]   Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease [J].
Bouguen, Guillaume ;
Levesque, Barrett G. ;
Feagan, Brian G. ;
Kavanaugh, Arthur ;
Peyrin-Biroulet, Laurent ;
Colombel, Jean-Frederic ;
Hanauer, Stephen B. ;
Sandborn, William J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (06) :1042-+
[5]   Limited uptake of ulcerative colitis "treat-to-target" recommendations in real-world practice [J].
Bryant, Robert V. ;
Costello, Samuel P. ;
Schoeman, Scott ;
Sathananthan, Dharshan ;
Knight, Emma ;
Lau, Su-Yin ;
Schoeman, Mark N. ;
Mountifield, Reme ;
Tee, Derrick ;
Travis, Simon P. L. ;
Andrews, Jane M. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (03) :599-607
[6]   Impact of inflammatory bowel disease on health-related quality of life [J].
Casellas, F ;
López-Vivancos, J ;
Vergara, M ;
Malagelada, JR .
DIGESTIVE DISEASES, 1999, 17 (04) :208-218
[7]   Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing [J].
Chang, Jeff ;
Leong, Rupert W. ;
Wasinger, Valerie C. ;
Ip, Matthew ;
Yang, Michael ;
Tri Giang Phan .
GASTROENTEROLOGY, 2017, 153 (03) :723-+
[8]   Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study [J].
Choi, Chang-Ho Ryan ;
Al Bakir, Ibrahim ;
Ding, Nik-Sheng ;
Lee, Gui-Han ;
Askari, Alan ;
Warusavitarne, Janindra ;
Moorghen, Morgan ;
Humphries, Adam ;
Ignjatovic-Wilson, Ana ;
Thomas-Gibson, Siwan ;
Saunders, Brian P. ;
Rutter, Matthew D. ;
Graham, Trevor A. ;
Hart, Ailsa L. .
GUT, 2019, 68 (03) :414-422
[9]   Predicting response after infliximab salvage in acute severe ulcerative colitis [J].
Choy, Matthew C. ;
Seah, Dean ;
Gorelik, Alexandra ;
An, Yoon-Kyo ;
Chen, Cheng-Yu ;
Macrae, Finlay A. ;
Sparrow, Miles P. ;
Connell, William R. ;
Moore, Gregory T. ;
Radford-Smith, Graham ;
Van Langenberg, Daniel R. ;
De Cruz, Peter .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (07) :1347-1352
[10]   Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis [J].
Colombel, Jean Frederic ;
Rutgeerts, Paul ;
Reinisch, Walter ;
Esser, Dirk ;
Wang, Yanxin ;
Lang, Yinghua ;
Marano, Colleen W. ;
Strauss, Richard ;
Oddens, Bjoern J. ;
Feagan, Brian G. ;
Hanauer, Stephen B. ;
Lichtenstein, Gary R. ;
Present, Daniel ;
Sands, Bruce E. ;
Sandborn, William J. .
GASTROENTEROLOGY, 2011, 141 (04) :1194-1201